Healthcare
Consortium sells LAB901
Archangel Informal Investment, Alliance Trust, Scottish Enterprise, Foresight, Noble Fund Managers and the Business Growth Fund have exited their stake in LAB901.
SLS Invest and SEB sell Sanos
SLS Invest and SEB have sold their stakes in Danish biotech company Sanos Bioscience A/S to Nordic Bioscience A/S.
Life Sciences Partners backs Activaero
Venture Capital firm Life Sciences Partners has lead a series-A finance round for Activaero with €3.5m.
Alven Capital et al. invest €3m in Happyview.fr
Alven Capital and a consortium of private investors have provided French online optician Happyview.fr with €3m of growth capital funding.
Inveready backs Transbiomed
Venture capital firm Inveready Seed Capital has invested $1.2m in a first round of finance in biotechnology company Transbiomed.
Realza-backed Plénida acquires 80% of Buccal
Grupo Plénida, a portfolio company of Realza Capital, has acquired an 80% stake in dental chain Buccal.
SEED Capital invests in Medichanical
SEED Capital has invested in Danish medical equipment company Medichanical Engineering ApS.
CIC LBO Partners et al. acquire AMS
CIC LBO Partners and CM-CIC Capital Privé have acquired French healthcare provider AMS from Capazanine for an undisclosed amount.
Consortium invests SEK 10m in Promimic
A consortium, consisting of ALMI Invest, Karolinska Development and several business angels among others, has injected SEK 10m in Gothenburg-based Promimic AB.
Ventizz exits Medos Medizintechnik
Private equity firm Ventizz Capital Partners has sold its 100% stake in German medical equipment provider Medos Medizintechnik AG to venture firm Zukunftsfonds Heilbronn GmbH & Co KG.
Altor sells Ferrosan to Pfizer
Altor has sold Danish consumer health company Ferrosan Consumer Health (FCH) to Pfizer Inc.
123Venture invests €11m in Philogeris Residences
123Venture has invested €11m in French retirement homes operator Philogeris Residences.
XAnge and EPF invest €4m in Clinique Développement
XAnge Private Equity and EPF Partners have invested €4m in French clinics operator Clinique Développement.
NBGI Private Equity invests in Sante
NBGI Private Equity has acquired a majority stake in Turkish operator of oncology therapy centres Sante Group for an undisclosed amount.
HBM BioVentures et al. exit PharmaSwiss
HBM BioVentures, Enterprise Investors and the other shareholders have sold 100% of Switzerland-based pharmaceutical company PharmaSwiss to Valeant Pharmaceuticals International for an approximate value of €350m.
Lundbeckfond Ventures et al. invest €11.4m in Nexstim
A consortium of investors led by Lundbeckfond Ventures has invested тЌ11.4m in Finnish medical equipment company Nexstim.
Riverside invests in Orliman
Global private equity firm The Riverside Company has invested in Spanish company Orliman, a Valencia-based manufacturer of non-invasive orthopaedic products.
Industrifonden leads investment in InDex
Industrifonden and existing shareholders, including SEB Venture Capital, have made a SEK 75m investment in InDex Pharmaceuticals AB.
Advent closes Priory buyout
Global private equity firm Advent International has acquired mental health and specialist care services provider The Priory Group from the Royal Bank of Scotland Group.
Emertec et al. invest €1.3m in Eviagenics
Emertec Gestion and CapDecisif Management have provided French biotech company Eviagenics with €1.3m of early-stage funding.
Sovereign-backed City & County acquires Quality Care Services
City & County Healthcare, a Sovereign Capital portfolio company, has acquired Irish home care provider Quality Care Services (QCS).
Auctus acquires Flemming Dental
Auctus has acquired a majority stake in Flemming Dental AG from a consortium of international financial investors.
Techfund et al. invest €2.5m in Polyplus
Techfund Capital Europe several and several CIC investment arms have provided French biotech company Polyplus-transfection with €2.5m of funding.
Sarsia Seed leads Avexxin funding round
Sarsia Seed has led a funding round in Norwegian pharma company Avexxin AS.